Biotech entity
pharma is the sole category represented across all 1 tracked stories. Teladoc Health is most often covered alongside Citi, which appears in 1 of these 1 story. Teladoc Health appears in 1 tracked Biotech story from March 10, 2026. The tracked stories average 3 original sources each.
Last mentioned: Mar 17, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. Teladoc Health is most often covered alongside Citi, which appears in 1 of these 1 story. Teladoc Health appears in 1 tracked Biotech story from March 10, 2026. The tracked stories average 3 original sources each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 19 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Teladoc Health. Shared-story counts are live from our verified record — not editorial picks.
Hims & Hers Health shares skyrocketed 41% following a strategic agreement with Novo Nordisk to distribute branded GLP-1 medications, including Ozempic, directly through its telehealth platform. The deal effectively ends a high-stakes patent dispute and transitions the company away from controversial compounded formulations toward FDA-approved branded therapies.
Teladoc Health is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
